세계의 방사성 의약품 주사기 시장 : 성장 동향과 경쟁 분석(2023-2029년)

The Radiopharmaceutical Injector market was valued at US$ 27.21 million in 2022 and is projected to reach US$ 46.18 million by 2029, at a CAGR of 7.35% during the forecast period (2023-2029).

The global key manufacturers of Radiopharmaceutical Injector include: Medrad, Inc.(Bayer), UNIVERSAL GIKEN, Comecer, Sumitomo Heavy Industries, Tema Sinergie, Lemer Pax, BQSV, and etc. In 2022, the global top five players hold a share approximately 84.23% in sales volume, and in term of revenue of Radiopharmaceutical Injector, the top five companies hold a share nearly 84.93%.

In terms of production side, this report researches the Radiopharmaceutical Injector capacity, production, growth rate, market share by manufacturers and regional level and country level, from 2018 to 2023, and forecast to 2029.

In terms of sales (consumption) side, this report focuses on the sales of Radiopharmaceutical Injector by regions (Countries), company, by Type and by Application. from 2018 to 2023 and forecast to 2029.

The global Radiopharmaceutical Injector market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Radiopharmaceutical Injector market. These figures have been provided in terms of both revenue and volume for the period 2018-2029. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

By Company

• Medrad, Inc.(Bayer)
• UNIVERSAL GIKEN
• Comecer
• Sumitomo Heavy Industries
• Tema Sinergie
• Lemer Pax
• BQSV

Segment by Type

• PET Radioactive Drugs Injector
• PET and SPECT Radioactive Drugs Injector

Segment by Application

• Hospitals and Clinics
• R&D Institution

Production by Region

• North America
• Europe
• Japan

Sales by Region

• North America
• United States
• Canada
• Mexico
• China
• Japan
• APAC (excluding China and Japan)
• South Korea
• Southeast Asia
• India
• Europe
• Germany
• France
• U.K.
• Italy
• Benelux
• Middle East & Africa, South America

Chapter Outline

• Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

• Chapter 2: Sales (consumption), revenue of Radiopharmaceutical Injector in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

• Chapter 3: Radiopharmaceutical Injector production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

• Chapter 4: Detailed analysis of Radiopharmaceutical Injector manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

• Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

• Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

• Chapter 7: North America by company, by Type, by Application and by country, sales, and revenue for each segment.

• Chapter 8: Europe by company, by Type, by Application and by country, sales, and revenue for each segment.

• Chapter 9: China by company, by Type, and by Application, sales, and revenue for each segment.

• Chapter 10: APAC (excluding China) by company, by Type, by Application and by country, sales, and revenue for each segment.

• Chapter 11: Middle East, Africa, and South America by company, by Type, by Application and by country, sales, and revenue for each segment.

• Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceutical Injector sales, revenue, price, gross margin, and recent development, etc.

• Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

• Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

• Chapter 15: The main points and conclusions of the report.

Table of Contents

1 Report Overview

• 1.1 Radiopharmaceutical Injector Definition
• 1.2 Market by Type
  • 1.2.1 Global Radiopharmaceutical Injector Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 PET Radioactive Drugs Injector
  • 1.2.3 PET and SPECT Radioactive Drugs Injector
• 1.3 Market by Application
  • 1.3.1 Global Radiopharmaceutical Injector Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Hospitals and Clinics
  • 1.3.3 R&D Institution
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Radiopharmaceutical Injector Sales

• 2.1 Global Radiopharmaceutical Injector Revenue Estimates and Forecasts 2018-2029
• 2.2 Global Radiopharmaceutical Injector Revenue by Region: 2018 VS 2022 VS 2029
• 2.3 Global Radiopharmaceutical Injector Revenue by Region
  • 2.3.1 Global Radiopharmaceutical Injector Revenue by Region (2018-2023)
  • 2.3.2 Global Radiopharmaceutical Injector Revenue by Region (2024-2029)
• 2.4 Global Radiopharmaceutical Injector Sales Quantity Estimates and Forecasts 2018-2029
• 2.5 Global Radiopharmaceutical Injector Sales Quantity by Region: 2018 VS 2022 VS 2029
• 2.6 Global Radiopharmaceutical Injector Sales Quantity by Region
  • 2.6.1 Global Radiopharmaceutical Injector Sales Quantity by Region (2018-2023)
  • 2.6.2 Global Radiopharmaceutical Injector Sales Quantity by Region (2024-2029)
• 2.7 North America
• 2.8 Europe
• 2.9 Japan
• 2.10 China
• 2.11 APAC (excluding China and Japan)
• 2.12 Middle East, Africa and South America

3 Global Production (Based on Production Site)

• 3.1 Global Radiopharmaceutical Injector Production Capacity (2018-2029)
• 3.2 Global Radiopharmaceutical Injector Production by Region: 2018 VS 2022 VS 2029
• 3.3 Global Radiopharmaceutical Injector Production by Region
  • 3.3.1 Global Radiopharmaceutical Injector Historic Production by Region (2018-2023)
  • 3.3.2 Global Radiopharmaceutical Injector Forecasted Production by Region (2024-2029)
  • 3.3.3 North America
  • 3.3.4 Europe
  • 3.3.5 Japan

4 Competition by Manufacturers

• 4.1 Global Radiopharmaceutical Injector Sales Quantity by Manufacturers
  • 4.1.1 Global Radiopharmaceutical Injector Sales Quantity by Manufacturers (2021-2023)
  • 4.1.2 Global Radiopharmaceutical Injector Sales Quantity Share by Manufacturers (2021-2023)
• 4.2 Global Radiopharmaceutical Injector Revenue by Manufacturers
  • 4.2.1 Global Radiopharmaceutical Injector Revenue by Manufacturers (2021-2023)
  • 4.2.2 Global Radiopharmaceutical Injector Revenue Share by Manufacturers (2021-2023)
• 4.3 Global Radiopharmaceutical Injector Sales Price by Manufacturers
• 4.4 Analysis of Competitive Landscape
  • 4.4.1 Manufacturers Market Concentration Ratio (CR5)
  • 4.4.2 Global Radiopharmaceutical Injector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.5 Global Key Manufacturers of Radiopharmaceutical Injector, Major Market Areas and Headquarters
• 4.6 Global Key Manufacturers of Radiopharmaceutical Injector, Product Offered
• 4.7 Global Key Manufacturers of Radiopharmaceutical Injector, Date of Enter into This Industry

5 Estimates and Forecasts by Type

• 5.1 Global Radiopharmaceutical Injector Sales Quantity by Type
  • 5.1.1 Global Radiopharmaceutical Injector Historical Sales Quantity by Type (2018-2023)
  • 5.1.2 Global Radiopharmaceutical Injector Forecasted Sales Quantity by Type (2024-2029)
  • 5.1.3 Global Radiopharmaceutical Injector Sales Quantity Market Share by Type (2018-2029)
• 5.2 Global Radiopharmaceutical Injector Revenue by Type
  • 5.2.1 Global Radiopharmaceutical Injector Historical Revenue by Type (2018-2023)
  • 5.2.2 Global Radiopharmaceutical Injector Forecasted Revenue by Type (2024-2029)
  • 5.2.3 Global Radiopharmaceutical Injector Revenue Market Share by Type (2018-2029)
• 5.3 Global Radiopharmaceutical Injector Price by Type
  • 5.3.1 Global Radiopharmaceutical Injector Price by Type (2018-2023)
  • 5.3.2 Global Radiopharmaceutical Injector Price Forecast by Type (2024-2029)

6 Market Size by Application

• 6.1 Global Radiopharmaceutical Injector Sales Quantity by Application
  • 6.1.1 Global Radiopharmaceutical Injector Historical Sales Quantity by Application (2018-2023)
  • 6.1.2 Global Radiopharmaceutical Injector Forecasted Sales Quantity by Application (2024-2029)
  • 6.1.3 Global Radiopharmaceutical Injector Sales Quantity Market Share by Application (2018-2029)
• 6.2 Global Radiopharmaceutical Injector Revenue by Application
  • 6.2.1 Global Radiopharmaceutical Injector Historical Revenue by Application (2018-2023)
  • 6.2.2 Global Radiopharmaceutical Injector Forecasted Revenue by Application (2024-2029)
  • 6.2.3 Global Radiopharmaceutical Injector Revenue Market Share by Application (2018-2029)
• 6.3 Global Radiopharmaceutical Injector Price by Application
  • 6.3.1 Global Radiopharmaceutical Injector Price by Application (2018-2023)
  • 6.3.2 Global Radiopharmaceutical Injector Price Forecast by Application (2024-2029)

7 North America

• 7.1 North America Radiopharmaceutical Injector Sales by Company
  • 7.1.1 North America Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
  • 7.1.2 North America Radiopharmaceutical Injector Revenue by Company (2021-2023)
• 7.2 North America Radiopharmaceutical Injector Market Size by Type
  • 7.2.1 North America Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
  • 7.2.2 North America Radiopharmaceutical Injector Sales Share by Type (2018-2029)
• 7.3 North America Radiopharmaceutical Injector Market Size by Application
  • 7.3.1 North America Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
  • 7.3.2 North America Radiopharmaceutical Injector Sales Share by Application (2018-2029)
• 7.4 North America Radiopharmaceutical Injector Market Size by Country
  • 7.4.1 North America Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029
  • 7.4.2 North America Radiopharmaceutical Injector Revenue by Country (2018-2029)
  • 7.4.3 North America Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)
  • 7.4.4 United States
  • 7.4.5 Canada
  • 7.4.6 Mexico

8 Europe

• 8.1 Europe Radiopharmaceutical Injector Sales by Company
  • 8.1.1 Europe Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
  • 8.1.2 Europe Radiopharmaceutical Injector Revenue by Company (2021-2023)
• 8.2 Europe Radiopharmaceutical Injector Market Size by Type
  • 8.2.1 Europe Radiopharmaceutical Injector Sales by Type (2018-2029)
  • 8.2.2 Europe Radiopharmaceutical Injector Sales Share by Type (2018-2029)
• 8.3 Europe Radiopharmaceutical Injector Market Size by Application
  • 8.3.1 Europe Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
  • 8.3.2 Europe Radiopharmaceutical Injector Sales Share by Application (2018-2029)
• 8.4 Europe Radiopharmaceutical Injector Market Size by Country
  • 8.4.1 Europe Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029
  • 8.4.2 Europe Radiopharmaceutical Injector Revenue by Country (2018-2029)
  • 8.4.3 Europe Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)
  • 8.4.4 Germany
  • 8.4.5 France
  • 8.4.6 U.K.
  • 8.4.7 Italy
  • 8.4.8 Benelux

9 China

• 9.1 China Radiopharmaceutical Injector Sales by Company
  • 9.1.1 China Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
  • 9.1.2 China Radiopharmaceutical Injector Revenue by Company (2021-2023)
• 9.2 China Radiopharmaceutical Injector Market Size by Type
  • 9.2.1 China Radiopharmaceutical Injector Sales by Type (2018-2029)
  • 9.2.2 China Radiopharmaceutical Injector Sales Share by Type (2018-2029)
• 9.3 China Radiopharmaceutical Injector Market Size by Application
  • 9.3.1 China Radiopharmaceutical Injector Sales by Application (2018-2029)
  • 9.3.2 China Radiopharmaceutical Injector Sales Share by Application (2018-2029)

10 Japan

• 10.1 Japan Radiopharmaceutical Injector Sales by Company
  • 10.1.1 Japan Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
  • 10.1.2 Japan Radiopharmaceutical Injector Revenue by Company (2021-2023)
• 10.2 Japan Radiopharmaceutical Injector Market Size by Type
  • 10.2.1 Japan Radiopharmaceutical Injector Sales by Type (2018-2029)
  • 10.2.2 Japan Radiopharmaceutical Injector Sales Share by Type (2018-2029)
• 10.3 Japan Radiopharmaceutical Injector Market Size by Application
  • 10.3.1 Japan Radiopharmaceutical Injector Sales by Application (2018-2029)
  • 10.3.2 Japan Radiopharmaceutical Injector Sales Share by Application (2018-2029)

11 APAC (excluding China and Japan)

• 11.1 APAC Radiopharmaceutical Injector Sales by Company
  • 11.1.1 APAC Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
  • 11.1.2 APAC Radiopharmaceutical Injector Revenue by Company (2021-2023)
• 11.2 APAC Radiopharmaceutical Injector Market Size by Type
  • 11.2.1 APAC Radiopharmaceutical Injector Sales by Type (2018-2029)
  • 11.2.2 APAC Radiopharmaceutical Injector Sales Share by Type (2018-2029)
• 11.3 APAC Radiopharmaceutical Injector Market Size by Application
  • 11.3.1 APAC Radiopharmaceutical Injector Sales by Application (2018-2029)
  • 11.3.2 APAC Radiopharmaceutical Injector Sales Share by Application (2018-2029)
• 11.4 APAC Radiopharmaceutical Injector Market Size by Region
  • 11.4.1 APAC Radiopharmaceutical Injector Revenue by Region: 2018 VS 2022 VS 2029
  • 11.4.2 APAC Radiopharmaceutical Injector Revenue by Region (2018-2029)
  • 11.4.3 APAC Radiopharmaceutical Injector Sales Quantity by Region (2018-2029)
  • 11.4.4 South Korea
  • 11.4.5 Southeast Asia
  • 11.4.6 India

12 Middle East, Africa and South America

• 12.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales by Company
  • 12.1.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
  • 12.1.2 Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Company (2021-2023)
• 12.2 Middle East, Africa and South America Radiopharmaceutical Injector Market Size by Type
  • 12.2.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
  • 12.2.2 Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Type (2018-2029)
• 12.3 Middle East, Africa and South America Radiopharmaceutical Injector Market Size by Application
  • 12.3.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
  • 12.3.2 Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Application (2018-2029)
• 12.4 Middle East, Africa and South America Radiopharmaceutical Injector Market Size by Country
  • 12.4.1 Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029
  • 12.4.2 Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country (2018-2029)
  • 12.4.3 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)

13 Company Profiles

• 13.1 Medrad, Inc.(Bayer)
  • 13.1.1 Medrad, Inc.(Bayer) Company Information
  • 13.1.2 Medrad, Inc.(Bayer) Overview
  • 13.1.3 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
  • 13.1.4 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Products and Services
• 13.2 UNIVERSAL GIKEN
  • 13.2.1 UNIVERSAL GIKEN Company Information
  • 13.2.2 UNIVERSAL GIKEN Overview
  • 13.2.3 UNIVERSAL GIKEN Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
  • 13.2.4 UNIVERSAL GIKEN Radiopharmaceutical Injector Products and Services
• 13.3 Comecer
  • 13.3.1 Comecer Company Information
  • 13.3.2 Comecer Overview
  • 13.3.3 Comecer Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
  • 13.3.4 Comecer Radiopharmaceutical Injector Products and Services
• 13.4 Sumitomo Heavy Industries
  • 13.4.1 Sumitomo Heavy Industries Company Information
  • 13.4.2 Sumitomo Heavy Industries Overview
  • 13.4.3 Sumitomo Heavy Industries Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
  • 13.4.4 Sumitomo Heavy Industries Radiopharmaceutical Injector Products and Services
• 13.5 Tema Sinergie
  • 13.5.1 Tema Sinergie Company Information
  • 13.5.2 Tema Sinergie Overview
  • 13.5.3 Tema Sinergie Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
  • 13.5.4 Tema Sinergie Radiopharmaceutical Injector Products and Services
• 13.6 Lemer Pax
  • 13.6.1 Lemer Pax Company Information
  • 13.6.2 Lemer Pax Overview
  • 13.6.3 Lemer Pax Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
  • 13.6.4 Lemer Pax Radiopharmaceutical Injector Products and Services
• 13.7 BQSV
  • 13.7.1 BQSV Company Information
  • 13.7.2 BQSV Overview
  • 13.7.3 BQSV Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
  • 13.7.4 BQSV Radiopharmaceutical Injector Products and Services

14 Value Chain and Sales Channels Analysis

• 14.1 Radiopharmaceutical Injector Value Chain Analysis
• 14.2 Radiopharmaceutical Injector Key Raw Materials
  • 14.2.1 Key Raw Materials
  • 14.2.2 Raw Materials Key Suppliers
• 14.3 Radiopharmaceutical Injector Production Mode & Process
• 14.4 Radiopharmaceutical Injector Sales and Marketing
  • 14.4.1 Radiopharmaceutical Injector Sales Channels
  • 14.4.2 Radiopharmaceutical Injector Distributors
• 14.5 Radiopharmaceutical Injector Customers

15 Radiopharmaceutical Injector Market Dynamics

• 15.1 Radiopharmaceutical Injector Industry Trends
• 15.2 Radiopharmaceutical Injector Market Drivers
• 15.3 Radiopharmaceutical Injector Market Challenges
• 15.4 Radiopharmaceutical Injector Market Restraints

16 Key Findings

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author Details
• 17.3 Disclaimer